Catherine Kubrak
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Catherine Kubrak has a total of 31 co-authors. Here are the top co-authors by number of shared publications:
- Vickie Elaine Baracos
Department of Oncology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Canada
6 shared publications - Brock Debenham
Department of Radiation Oncology, Cross Cancer Institute, Edmonton, Alberta, Canada
3 shared publications Kärin Olson
University of Alberta
3 shared publicationsLouise Jensen
3 shared publications- Brennan Olson
Mayo Clin, Dept Otolaryngol Head & Neck Surg, Rochester, MN USA
2 shared publications - Faith D. Ottery
Astellas Pharma Global Development, Northbrook, USA
2 shared publications
Latest Publications
- 17 June 2024
- Published by Elsevier in Clinical Nutrition
- Vol. 43 (8) , 1738-1739
Sarcopenia etymology: Sarcos (flesh) penia (poverty) i.e. absence, lack or deficiency of a body constituent
- 17 June 2024
- Published by Elsevier in Clinical Nutrition
- Vol. 43 (8) , 1738-1739
Sarcopenia etymology: Sarcos (flesh) penia (poverty) i.e. absence, lack or deficiency of a body constituent
- Open Access
- 22 February 2024
- Published by Elsevier in Clinical Nutrition
- Vol. 43 (4) , 989-1000
Quantifying the severity of sarcopenia in patients with cancer of the head and neck
- 22 February 2024
- Published by Elsevier in Clinical Nutrition
- Vol. 43 (4) , 989-1000
Open AccessQuantifying the severity of sarcopenia in patients with cancer of the head and neck
- Open Access
Meeting Minimum ESPEN Energy Recommendations Is Not Enough to Maintain Muscle Mass in Head and Neck Cancer Patients
The relationship between dietary intake and body composition changes during cancer treatment has not been well characterized. The aim of this study was to compare dietary intake at diagnosis and end of treatment in relation to changes in muscle mass and adiposity in head and neck cancer (HNC) patients. Dietary intakes (three-day food record) and body composition using computed tomography (CT) were assessed at diagnosis (baseline) and after treatment completion (post-treatment). Skeletal muscle (SM) loss was explored as a consequence of energy and protein intake in relation to the minimum and maximum European Society of Parenteral and Enteral Nutrition (ESPEN) guidelines. Higher energy intakes (kcal/kg/day) and increases in energy intake (%) from baseline to post-treatment were correlated with attenuated muscle loss (r = 0.62, p < 0.01; r = 0.47, p = 0.04, respectively). Post-treatment protein intake demonstrated a weak positive correlation (r = 0.44, p = 0.05) with muscle loss, which did not persist when controlling for covariates. Meeting minimum ESPEN energy guidelines (25 kcal/kg/day) did not attenuate SM loss, whereas intakes >30 kcal/kg/day resulted in fewer participants losing muscle. Greater baseline adiposity correlated with greater SM loss (p < 0.001). Energy intakes of 30 kcal/kg/day may be required to protect against SM loss during treatment in HNC patients. The influence of adiposity on SM loss requires further exploration.
Open AccessMeeting Minimum ESPEN Energy Recommendations Is Not Enough to Maintain Muscle Mass in Head and Neck Cancer Patients
The relationship between dietary intake and body composition changes during cancer treatment has not been well characterized. The aim of this study was to compare dietary intake at diagnosis and end of treatment in relation to changes in muscle mass and adiposity in head and neck cancer (HNC) patients. Dietary intakes (three-day food record) and body composition using computed tomography (CT) were assessed at diagnosis (baseline) and after treatment completion (post-treatment). Skeletal muscle (SM) loss was explored as a consequence of energy and protein intake in relation to the minimum and maximum European Society of Parenteral and Enteral Nutrition (ESPEN) guidelines. Higher energy intakes (kcal/kg/day) and increases in energy intake (%) from baseline to post-treatment were correlated with attenuated muscle loss (r = 0.62, p < 0.01; r = 0.47, p = 0.04, respectively). Post-treatment protein intake demonstrated a weak positive correlation (r = 0.44, p = 0.05) with muscle loss, which did not persist when controlling for covariates. Meeting minimum ESPEN energy guidelines (25 kcal/kg/day) did not attenuate SM loss, whereas intakes >30 kcal/kg/day resulted in fewer participants losing muscle. Greater baseline adiposity correlated with greater SM loss (p < 0.001). Energy intakes of 30 kcal/kg/day may be required to protect against SM loss during treatment in HNC patients. The influence of adiposity on SM loss requires further exploration.
- 14 July 2013
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 21 (11) , 3127-3136
The head and neck symptom checklist©: an instrument to evaluate nutrition impact symptoms effect on energy intake and weight loss
This study aimed to validate the Head and Neck Patient Symptom Checklist© (HNSC©) by tracing the prevalence and interference with eating of nutrition impact symptoms (NIS) over time and by examining relationships among NIS included in the HNSC, energy intake, and weight loss. Height, weight, 3-day diet records, and HNSC© were obtained at baseline, posttreatment, and 2.5 month follow-up for 52 treatment–naive head and neck cancer (HNC) patients. Relationships among energy intake, weight loss, age, sex, treatment, tumor stage, and NIS were evaluated using general estimating equation (GEE) modeling. Cumulative hazard (CH) analysis was used to determine the time and risk of weight loss. From baseline to posttreatment, 71 % of patients had 5 % body weight loss. Despite energy intakes returning to baseline levels at follow-up, 88 % of patients continued to lose weight. At posttreatment, 100 % of patients reported 2 or more NIS (range 2–12); these symptoms were still present at follow-up in 83 % of the patients. Univariate GEE analysis demonstrated that most NIS predicted energy intake and weight loss, while multivariate GEE analysis showed that depression, dysphagia, and sore mouth predicted energy intake, and dysphagia and sore mouth predicted weight loss. CH analysis showed that NIS accelerated the time and probability of weight loss. The HNSC© is a valid tool for assessing NIS in HNC. Identification of NIS may aid in the management of symptoms associated with reduced energy intake and weight loss and thus decrease the malnutrition risk in HNC patients.
- 14 July 2013
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 21 (11) , 3127-3136
The head and neck symptom checklist©: an instrument to evaluate nutrition impact symptoms effect on energy intake and weight loss
This study aimed to validate the Head and Neck Patient Symptom Checklist© (HNSC©) by tracing the prevalence and interference with eating of nutrition impact symptoms (NIS) over time and by examining relationships among NIS included in the HNSC, energy intake, and weight loss. Height, weight, 3-day diet records, and HNSC© were obtained at baseline, posttreatment, and 2.5 month follow-up for 52 treatment–naive head and neck cancer (HNC) patients. Relationships among energy intake, weight loss, age, sex, treatment, tumor stage, and NIS were evaluated using general estimating equation (GEE) modeling. Cumulative hazard (CH) analysis was used to determine the time and risk of weight loss. From baseline to posttreatment, 71 % of patients had 5 % body weight loss. Despite energy intakes returning to baseline levels at follow-up, 88 % of patients continued to lose weight. At posttreatment, 100 % of patients reported 2 or more NIS (range 2–12); these symptoms were still present at follow-up in 83 % of the patients. Univariate GEE analysis demonstrated that most NIS predicted energy intake and weight loss, while multivariate GEE analysis showed that depression, dysphagia, and sore mouth predicted energy intake, and dysphagia and sore mouth predicted weight loss. CH analysis showed that NIS accelerated the time and probability of weight loss. The HNSC© is a valid tool for assessing NIS in HNC. Identification of NIS may aid in the management of symptoms associated with reduced energy intake and weight loss and thus decrease the malnutrition risk in HNC patients.
- 22 June 2012
- Published by Wiley in Head & Neck
- Vol. 35 (5) , 695-703
Clinical determinants of weight loss in patients receiving radiation and chemoirradiation for head and neck cancer: A prospective longitudinal view
Background: We aimed to determine the effects of systemic inflammation and symptoms of head and neck cancer patients on dietary intake and weight in relation to mode of treatment.Methods: In all, 38 orally fed patients had intake, weight, C‐reactive protein (CRP), and symptoms prospectively assessed at baseline, post‐treatment, and follow‐up.Results: Intake/weight declined and CRP increased substantially in chemoirradiation patients (−11.4 ± 5.2 kg, −1214 kcal/day, 23.4 ± 24.9 mg/L; p < .05) versus radiotherapy patients (−3.5 ± 4.8 kg, −483 kcal/day, 8.3 ± 13.9 mg/L) during posttreatment (repeated‐measures ANOVA). Multivariate generalized estimating equations modeling identified reduced swallowing capacity was a key predictor of energy intake in both treatment groups (p < .001); multiple symptoms experienced by radiotherapy/chemoirradiation patients were significant predictors of weight loss; additionally, in chemoirradiation patients, CRP was an independent predictor of weight loss (p < .001).Conclusions: Treatment of symptoms and systemic inflammation are important clinical targets to manage weight loss in patients with head and neck cancer, especially those treated with chemoirradiation. Head Neck, 2013
- 22 June 2012
- Published by Wiley in Head & Neck
- Vol. 35 (5) , 695-703
Clinical determinants of weight loss in patients receiving radiation and chemoirradiation for head and neck cancer: A prospective longitudinal view
Background: We aimed to determine the effects of systemic inflammation and symptoms of head and neck cancer patients on dietary intake and weight in relation to mode of treatment.Methods: In all, 38 orally fed patients had intake, weight, C‐reactive protein (CRP), and symptoms prospectively assessed at baseline, post‐treatment, and follow‐up.Results: Intake/weight declined and CRP increased substantially in chemoirradiation patients (−11.4 ± 5.2 kg, −1214 kcal/day, 23.4 ± 24.9 mg/L; p < .05) versus radiotherapy patients (−3.5 ± 4.8 kg, −483 kcal/day, 8.3 ± 13.9 mg/L) during posttreatment (repeated‐measures ANOVA). Multivariate generalized estimating equations modeling identified reduced swallowing capacity was a key predictor of energy intake in both treatment groups (p < .001); multiple symptoms experienced by radiotherapy/chemoirradiation patients were significant predictors of weight loss; additionally, in chemoirradiation patients, CRP was an independent predictor of weight loss (p < .001).Conclusions: Treatment of symptoms and systemic inflammation are important clinical targets to manage weight loss in patients with head and neck cancer, especially those treated with chemoirradiation. Head Neck, 2013
- 22 July 2009
- Published by Wiley in Head & Neck
- Vol. 32 (3) , 290-300
Nutrition impact symptoms: Key determinants of reduced dietary intake, weight loss, and reduced functional capacity of patients with head and neck cancer before treatment
Background.: Our aim was to evaluate the prevalence and relationship of symptoms with reduced dietary intake, weight, and functional capacity in patients with head and neck cancer.Methods.: Three hundred forty‐one patients were prospectively screened with the patient‐generated subjective global assessment before treatment. Logistic analysis was used to relate symptoms to reduced dietary intake, weight, and functional capacity. Cumulative hazard analysis was performed to determine the time and risk of weight loss of each symptom. Survival analysis was performed with Cox proportional hazards model.Results.: Anorexia, dysphagia, mouth sores, and others were significant predictors of reduced dietary intake and weight. Symptom presence accelerated the time and probability of weight loss. Body mass index ≤18.5 related to overall survival (p value = .001).Conclusions.: Symptoms present before treatment may adversely affect the dietary intake, weight, and functional capacity of patients. Symptom treatment and management is critical to weight loss prevention. © 2009 Wiley Periodicals, Inc. Head Neck, 2010
- 22 July 2009
- Published by Wiley in Head & Neck
- Vol. 32 (3) , 290-300
Nutrition impact symptoms: Key determinants of reduced dietary intake, weight loss, and reduced functional capacity of patients with head and neck cancer before treatment
Background.: Our aim was to evaluate the prevalence and relationship of symptoms with reduced dietary intake, weight, and functional capacity in patients with head and neck cancer.Methods.: Three hundred forty‐one patients were prospectively screened with the patient‐generated subjective global assessment before treatment. Logistic analysis was used to relate symptoms to reduced dietary intake, weight, and functional capacity. Cumulative hazard analysis was performed to determine the time and risk of weight loss of each symptom. Survival analysis was performed with Cox proportional hazards model.Results.: Anorexia, dysphagia, mouth sores, and others were significant predictors of reduced dietary intake and weight. Symptom presence accelerated the time and probability of weight loss. Body mass index ≤18.5 related to overall survival (p value = .001).Conclusions.: Symptoms present before treatment may adversely affect the dietary intake, weight, and functional capacity of patients. Symptom treatment and management is critical to weight loss prevention. © 2009 Wiley Periodicals, Inc. Head Neck, 2010
- 1 September 2007
- Published by Wolters Kluwer Health in Cancer Nursing
- Vol. 30 (5) , E1-E6
Critical Evaluation of Nutrition Screening Tools Recommended for Oncology Patients
Malnutrition ranges from 20% to 80% in oncology patients. Malnutrition has been associated with reduced response to treatment, survival, and quality of life. Therefore, screening for malnutrition in patients with cancer is recommended by clinical practice groups including the Oncology Nursing Society. Nurses are in an ideal position to carry out nutrition screening. Three nutrition screening tools that have been recommended for use with oncology patients by the Oncology Nursing Society are critically evaluated. The Patient Generated-Subjective Global Assessment has demonstrated diagnostic value in oncology patients at risk of malnutrition or who are malnourished.
- 1 September 2007
- Published by Wolters Kluwer Health in Cancer Nursing
- Vol. 30 (5) , E1-E6
Critical Evaluation of Nutrition Screening Tools Recommended for Oncology Patients
Malnutrition ranges from 20% to 80% in oncology patients. Malnutrition has been associated with reduced response to treatment, survival, and quality of life. Therefore, screening for malnutrition in patients with cancer is recommended by clinical practice groups including the Oncology Nursing Society. Nurses are in an ideal position to carry out nutrition screening. Three nutrition screening tools that have been recommended for use with oncology patients by the Oncology Nursing Society are critically evaluated. The Patient Generated-Subjective Global Assessment has demonstrated diagnostic value in oncology patients at risk of malnutrition or who are malnourished.
- 1 August 2007
- Published by Elsevier in International Journal of Nursing Studies
- Vol. 44 (6) , 1036-1054
Malnutrition in acute care patients: A narrative review
- 1 August 2007
- Published by Elsevier in International Journal of Nursing Studies
- Vol. 44 (6) , 1036-1054
Malnutrition in acute care patients: A narrative review